Cancer staging explained: what Stage 1, 2, 3 and 4 actually mean

Being told "it is stage three" without being told what that means is one of the more common failures of communication in medicine. This page fills the gap.

What staging is trying to answer

Staging answers one question: how far has the cancer travelled from where it started?

Not how aggressive it is, not how it will be treated, not how long someone will live. Just distance. Everything else is built on top of that answer, which is why it comes first.

The three-letter system underneath

Almost all solid cancers are described using TNM, and the stage number is derived from it.

T — tumour. How large the primary tumour is and how deeply it has invaded. T1 is small and confined; T4 has grown into neighbouring structures. Note that for many cancers, depth of invasion matters more than diameter.

N — nodes. Whether cancer cells have reached the lymph nodes, and how many and how far away. N0 means none. N1 to N3 describe increasing involvement. Lymph nodes are the drainage network of the body, and they are usually the first stop on a cancer's journey.

M — metastasis. Whether it has spread to distant organs. M0 means no. M1 means yes — most often to liver, lungs, bones or brain.

So a report reading T2 N1 M0 means: a moderately sized primary tumour, some nearby lymph nodes involved, nothing distant.

How TNM becomes a stage number

The combinations are grouped into stages. The grouping differs by cancer type — the same TNM means different stages in breast and in colon cancer — but the pattern is consistent:

• Stage 0 — abnormal cells present but not yet invading. Sometimes called carcinoma in situ.
• Stage 1 — small, confined to the organ of origin, no nodes.
• Stage 2 — larger, or with limited nearby node involvement.
• Stage 3 — extensive local disease and/or significant regional node involvement, still without distant spread.
• Stage 4 — spread to distant organs.

Two things worth knowing. First, the numbers are not evenly spaced: the gap between stage 3 and stage 4 is usually far larger, in both treatment and outlook, than the gap between 1 and 2. Second, stage 4 does not mean untreatable. For several cancers — testicular, some lymphomas, certain neuroendocrine tumours — stage 4 disease is routinely treated with the intention to cure. For others it is managed as a long-term condition for many years.

Stage is not grade

These are constantly confused.

Stage is about where the cancer is — its extent in the body. Grade is about how it looks down a microscope — how abnormal the cells appear, which reflects how fast it is likely to grow.

A small, high-grade tumour and a large, low-grade one are very different problems. You need both numbers.

Where PET/CT fits

Staging can be done clinically, by examination, and radiologically, by imaging. PET/CT has become central to radiological staging for a specific reason: it detects disease in structures that are not yet enlarged.

A lymph node that is 8 mm across looks normal to a CT scanner, which judges by size. If it is packed with metabolically active tumour cells, PET sees it anyway. That is why PET/CT frequently changes the stage assigned by conventional imaging — usually upward, occasionally downward when a suspicious lesion turns out to be inert.

Published studies have repeatedly found that PET/CT alters intended management in roughly a quarter to a third of patients. That could mean cancelling an operation because distant disease was found, or proceeding to a curative operation because a worrying spot turned out to be benign.

This is also where scanner quality matters. Whether a 5 mm node is confidently reported depends on the resolution of the machine and the experience of the reader.

Restaging, and why the word appears on your prescription

Staging is done at diagnosis, before treatment. Restaging is done after treatment, or partway through, to see what has changed.

Restaging uses standardised criteria so that the comparison is objective rather than impressionistic:

• RECIST 1.1 measures changes in lesion size.
• PERCIST measures changes in metabolic activity — often more informative, since a tumour can die without shrinking.
• Deauville is a five-point scale used in lymphoma, comparing residual uptake to the liver and blood pool.

These labels are why a report reads "PERCIST: partial metabolic response" rather than "looks a bit better". They allow your oncologist to compare this scan against the last one — even if the last one was done at a different centre.

For that comparison to work, the earlier images must actually be available. Always carry your previous scans on CD, not just the printed report.

What to ask your doctor

Take these to your next appointment:

1. What is my stage, and what is the TNM behind it?
2. What is the grade, and does it change the plan?
3. Is the goal of treatment cure, control, or symptom relief? (This question is uncomfortable and it is the most important one on the list.)
4. What will we use to tell whether treatment is working, and when will we check?
5. Are there tests that might change the plan that we have not yet done?

Write the answers down. Nobody remembers a consultation like this accurately afterwards, and there is no shame in taking notes or recording it with permission.

A closing note

A stage is a description, not a prophecy. It describes a distribution of disease at one moment in time, and it exists so that treatment can be matched to the situation properly. Survival statistics attached to stages are averages drawn from large groups treated years ago — they are how populations behaved, not how you will.

Ask what your stage means for your treatment plan. That is the question the number was designed to answer.